FTRE Insider Trading

Insider Ownership Percentage: 0.12%
Insider Buying (Last 12 Months): $298,700.00
Insider Selling (Last 12 Months): $226,168.06

Fortrea Insider Trading History Chart

This chart shows the insider buying and selling history at Fortrea by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$226ksoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$500k$0$500kTotal Insider BuyingTotal Insider Selling

Fortrea Share Price & Price History

Current Price: $8.03
Price Change: Price Decrease of -0.33 (-3.95%)
As of 03/28/2025 05:00 PM ET

This chart shows the closing price history over time for FTRE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$8.03Closing price on 03/29/25:

SEC Filings (Institutional Ownership Changes) for Fortrea (NASDAQ:FTRE)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at FTRE by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$75Mbought$49MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$200M-$100M$0$100M$200MTotal InflowsTotal Outflows
Fortrea logo
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
Read More on Fortrea

Today's Range

Now: $8.03
Low: $8.00
High: $8.38

50 Day Range

MA: $13.39
Low: $8.03
High: $18.70

52 Week Range

Now: $8.03
Low: $8.00
High: $40.63

Volume

1,752,200 shs

Average Volume

1,480,665 shs

Market Capitalization

$724.31 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.34

Who are the company insiders with the largest holdings of Fortrea?

Fortrea's top insider shareholders include:
  1. Thomas Pike (CEO)
  2. Jill G Mcconnell (CFO)
  3. Peter M Neupert (Director)
  4. James S Hanson (General Counsel)
Learn More about top insider investors at Fortrea.

Who are the major institutional investors of Fortrea?

Fortrea's top institutional investors include:
  1. Vanguard Group Inc. — 11.02%
  2. FMR LLC — 9.02%
  3. Starboard Value LP — 8.34%
  4. Sessa Capital IM L.P. — 7.42%
  5. Beck Mack & Oliver LLC — 6.28%
  6. Corvex Management LP — 3.88%
Learn More about top institutional investors of Fortrea stock.

Which institutional investors are selling Fortrea stock?

Within the previous quarter, FTRE stock was sold by these institutional investors:
  1. Victory Capital Management Inc.
  2. Starboard Value LP
  3. Coliseum Capital Management LLC
  4. Magnetar Financial LLC
  5. Bank of America Corp DE
  6. CenterBook Partners LP
  7. Jacobs Levy Equity Management Inc.
  8. Sessa Capital IM L.P.
Within the last year, company insiders that have sold Fortrea company stock include:
  1. Thomas Pike (CEO)
  2. Jill G Mcconnell (CFO)
Learn More investors selling Fortrea stock.

Which institutional investors are buying Fortrea stock?

Within the last quarter, FTRE stock was purchased by institutional investors including:
  1. FMR LLC
  2. Corvex Management LP
  3. Millennium Management LLC
  4. Point72 Asset Management L.P.
  5. Renaissance Technologies LLC
  6. Peregrine Capital Management LLC
  7. Casdin Capital LLC
  8. Trexquant Investment LP
During the previous year, these company insiders have bought Fortrea stock:
  1. Thomas Pike (CEO)
  2. Jill G Mcconnell (CFO)
  3. Peter M Neupert (Director)
Learn More investors buying Fortrea stock.